Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Apr 15, 2026; 18(4): 116821
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.116821
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.116821
Table 2 Comparison of serum chitinase-3-like protein 1 levels in liver diseases patients
| Group | Group serum CHI3L1 level (ng/mL) | ||
| 25th percentile | 50th percentile | 75th percentile | |
| Health control | 36.79 | 40.99 | 51.47 |
| Virus hepatitis | 36.81 | 58.91 | 85.39 |
| Non-virus hepatitis | 34.50 | 50.89 | 77.34 |
| Liver cirrhosis | 61.58 | 100.13 | 161.38a,b,c |
| HCC | 67.38 | 141.07 | 271.77a,b,c |
| HCC patients after radical resection | 32.77 | 64.27 | 130.78d,e |
| HCC recurrence | 35.09 | 156.00 | 554.6a,b,c |
- Citation: Zhang HY, Zhang RL, Jia YY, Liu Y, Zhu L, Liu F, Rao HY. Diagnostic value of serum chitinase-3-like protein 1 for liver fibrosis/cirrhosis and hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18(4): 116821
- URL: https://www.wjgnet.com/1948-5204/full/v18/i4/116821.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i4.116821